Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India

Asma Munir, Narender Kumar, Suresh Babu Ramalingam, Sembulingam Tamilzhalagan, Siva Kumar Shanmugam, Alangudi Natarajan Palaniappan, Dina Nair, Padma Priyadarshini, Mohan Natarajan, Srikanth Tripathy, Uma Devi Ranganathan, Sharon J. Peacock, Julian Parkhill, Tom L. Blundell, Sony MalhotraScientific 2019 · DOI

TL;DR

This study investigates the genetic basis of isoniazid (INH) and rifampicin (RIF) resistance in Mycobacterium tuberculosis from Southern India, revealing common mutations and using computational modeling to explore their impact on drug target proteins. The findings highlight the importance of understanding these genetic determinants for developing new diagnostics and therapeutics against drug-resistant tuberculosis.

What Problem Does This Paper Address?

Drug-resistant tuberculosis (TB) is a major global health threat, with resistance arising primarily from spontaneous mutations in the Mycobacterium tuberculosis genome. While many resistance-conferring mutations are known, a systematic analysis of their genetic background and precise impact on drug target proteins has been lacking. This is particularly crucial in regions like Southern India, which have a high burden of TB and a predominance of specific M. tuberculosis lineages (lineage 1 and 3). Understanding these mechanisms is vital for identifying new drug targets and designing more effective treatments.

Methods

The researchers employed a multi-pronged approach:

  • Whole-Genome Sequencing (WGS): They sequenced the genomes of 98 clinical M. tuberculosis isolates from Southern India.
  • Phenotypic Drug Susceptibility Testing (DST): Isolates were tested for resistance to INH and RIF using standard methods.
  • SNP-based Phylogenetic Analysis: A phylogenetic tree was constructed to understand the lineage diversity of the isolates.
  • Mutation Identification: WGS data was analyzed to identify genetic mutations associated with INH and RIF resistance.
  • Computational Modeling:
    • Protein Stability Prediction: Statistical (SDM2) and machine-learning (mCSM) approaches were used to predict the impact of mutations on protein stability.
  • Protein-Protein Interaction Prediction: mCSM-PPI was used to assess how mutations affect interactions between proteins.
  • Protein-Ligand Interaction Prediction: mCSM-lig was employed to evaluate the effect of mutations on the binding affinity of drugs to their targets.
  • Interatomic Interaction Analysis: Tools like Intermezzo were used to visualize and analyze specific molecular interactions.

Datasets

  • 98 clinical M. tuberculosis isolates: Collected from patients at the Government Hospital for Thoracic Medicine, Chennai, India. These isolates were characterized for both drug resistance (phenotypic) and genetic makeup (whole-genome sequencing).
  • Publicly available mutation databases: Used for comparison and identification of known resistance-conferring mutations.

Key Insights and Ideas

  • Lineage Dominance: Lineage 1 (Indo-Oceanic) was the most prevalent lineage in the study cohort, which is consistent with previous findings for Southern India. This highlights the need for studies focusing on these less globally dominant lineages.
  • Common Resistance Mutations: The study confirmed well-established mutations as the primary drivers of INH (S315T in katG) and RIF (S450L in rpoB) resistance in this population.
  • Beyond Orthosteric Binding: The computational analysis suggests that drug-resistant mutations can affect drug targets not only by directly interfering with the active site (orthosteric) but also through allosteric mechanisms, influencing protein conformation and interactions from distant sites, potentially even at protein-protein interfaces. This broadens our understanding of resistance mechanisms.
  • Fitness Cost and Compensatory Mutations: The most frequent resistance mutations (S315T in katG and S450L in rpoB) were predicted to have a near-neutral effect on protein stability, suggesting a low fitness cost. This could explain their high prevalence. The study also noted the presence of rpoC mutations in RIF-resistant isolates, which are often considered compensatory.

Key Results

  • Phenotypic Resistance: 34 out of 98 isolates were resistant to INH, and 24 were resistant to RIF.
  • Genetic Determinants:
    • INH Resistance: Primarily driven by mutations in katG (S315T being the most frequent, 67.6%) and fabG1 promoter (C-15T, 14.7%). Together, these accounted for 82% of INH resistance.
  • RIF Resistance: Primarily driven by mutations in rpoB. S450L (52%) and H445Y (26%) were the most frequent mutations.
  • Computational Predictions:
    • Mutations in katG were predicted to be slightly destabilizing or near neutral, suggesting they interfere with drug binding rather than drastically altering protein structure.
  • Mutations in inhA and rpoB were predicted to decrease drug affinity, leading to resistance.
  • Mutations in rpoC were predicted to impact protein-protein interactions, suggesting a role in compensatory mechanisms.

Limitations and Future Work

  • Sample Size: While 98 isolates provide valuable insights, a larger sample size could further strengthen the statistical power and identify rarer mutations.
  • Computational vs. Experimental Validation: The study relies heavily on computational predictions. Experimental validation of these predicted effects would be crucial for definitive confirmation.
  • Limited Drug Targets: The study focused on INH and RIF resistance. Expanding the analysis to other first- and second-line drugs would provide a more comprehensive picture of drug resistance in this population.
  • Future Directions: The authors suggest that their computational approach is useful for rapid analysis of large datasets and can aid in understanding drug resistance mechanisms. Future work could involve experimental validation of these predictions and extending the analysis to a broader range of drugs and M. tuberculosis lineages. The identification of potential compensatory mutations also opens avenues for exploring novel therapeutic strategies.

Summary updated

Abstract

Drug-resistant tuberculosis (TB), one of the leading causes of death worldwide, arises mainly from spontaneous mutations in the genome of Mycobacterium tuberculosis. There is an urgent need to understand the mechanisms by which the mutations confer resistance in order to identify new drug targets and to design new drugs. Previous studies have reported numerous mutations that confer resistance to anti-TB drugs, but there has been little systematic analysis to understand their genetic background and the potential impacts on the drug target stability and/or interactions. Here, we report the analysis of whole-genome sequence data for 98 clinical M. tuberculosis isolates from a city in southern India. The collection was screened for phenotypic resistance and sequenced to mine the genetic mutations conferring resistance to isoniazid and rifampicin. The most frequent mutation among isoniazid and rifampicin isolates was S315T in katG and S450L in rpoB respectively. The impacts of mutations on protein stability, protein-protein interactions and protein-ligand interactions were analysed using both statistical and machine-learning approaches. Drug-resistant mutations were predicted not only to target active sites in an orthosteric manner, but also to act through allosteric mechanisms arising from distant sites, sometimes at the protein-protein interface.
BibTeX
@inproceedings{munir2019identification,
  author = {Asma Munir and Narender Kumar and Suresh Babu Ramalingam and Sembulingam Tamilzhalagan and Siva Kumar Shanmugam and Alangudi Natarajan Palaniappan and Dina Nair and Padma Priyadarshini and Mohan Natarajan and Srikanth Tripathy and Uma Devi Ranganathan and Sharon J. Peacock and Julian Parkhill and Tom L. Blundell and Sony Malhotra},
  title = {{Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-46756-x},
}
Figure